Manufacturing, Gene Therapies

Updating Research, Development, and Regulatory Models for Gene Therapy

December 17, 2018

PharmTech Sponsored eBooks

Orchard Therapeutics Announces New Gene Therapy Manufacturing Facility

December 13, 2018

A new facility in California will expand Orchard Therapeutic’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells.

Yposkesi Announces Agreement in Principle with Axovant to Expand Gene Therapy Manufacturing Capacity

November 30, 2018

Contract development and manufacturing organization (CDMO), Yposkesi, has entered into an agreement in principle with Axovant Sciences.

Manufacturing Challenges Limit Gene Therapy Development

November 16, 2018

Moving forward with gene therapy development requires a “quantum leap” in manufacturing capabilities.

Can Gene Therapy Deliver on its Promise?

November 14, 2018

Improving the manufacturing of gene therapy vectors will be crucial to making advanced treatments accessible to more patients who need them, agreed panelists at the 2018 Galien Forum.

MilliporeSigma Offers Insect Platform for Viral Vaccines and Gene Therapy Development

October 15, 2018

The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.

Astellas Acquires Gene Therapy Company Quethera

August 17, 2018

The acquisition will strengthen Astellas Pharma’s position in ophthalmology.

Novartis’ AveXis to Invest $55 Million in New Gene Therapy Manufacturing Facility

May 25, 2018

The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.

CRISPR Shows Promise for Enhancing Gene Therapy

April 24, 2018

Scientists at Washington University School of Medicine in St. Louis have developed a new method that could help increase the long-term effectiveness of gene therapy.

Lonza Opens Dedicated Cell and Gene Therapy Manufacturing Facility

April 10, 2018

The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.